Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
EMulate Therapeutics Logo
EMulate Therapeutics CB Rank
260406
Heat Score
72
EMulate Therapeutics is a clinical-stage therapeutic device company.
Founded
obfuscation
Private Seattle, Washington, United States11-50 emulatetx.com
Biotechnology
Overview

EMulate Therapeutics
Heat Score
72

Growth Score
pts
in past quarter
Heat Score 72
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About EMulate Therapeutics

CB Rank
260406
EMulate Therapeutics is a clinical-stage therapeutic device company.
Founded
obfuscation
Private Seattle, Washington, United States11-50 emulatetx.com
Biotechnology

Details

Operating Status Active
Company Type For Profit
Founders  John Butters, Lisa Butters
Phone Number 206.708.2288
Contact Email corporate@emulatetx.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Insight

See this Growth Insight
EMulate Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

ulRFE Technology
A proprietary technology using ultra-low radio frequency energy to produce therapeutic biological effects, currently in clinical testing for brain cancer and preclinical testing for pain and mental health disorders.
Cellsana Therapeutics
A subsidiary focused on oncology, preparing for phase III trials for glioblastoma and diffuse midline glioma, with potential applications in various solid tumors.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Board Members and Advisors 1 Contacts 9

Board Members and Advisors

News

News and Press

News•Dec 22, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 28, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 31, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

72
-2%
 in past month

IT Spend

$735.6KThis year, EMulate Therapeutics is projected to spend $735.6K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Deal Review Logo
Deal Review
75

Actively Used Products

5EMulate Therapeutics uses 5 technology products and services including HTML5, Amazon Route 53, and  Wordpress, according to G2 Stack.

Active Website Tech Count

3EMulate Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Pound Sterling.
Sub-Organizations
Frequently Asked Questions

Where is EMulate Therapeutics's headquarters? EMulate Therapeutics is located in Seattle, Washington, United States.Who are EMulate Therapeutics's competitors? Alternatives and possible competitors to EMulate Therapeutics may include Neurovalens, InSightec, and  Brainsway.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|